 |
| Glaxosmithkline Pharmaceuticals Ltd |
Pharmaceuticals - Multinational |
|
|
| BSE Code |
|
| 500660 |
|
|
|
| ISIN Demat |
|
| INE159A01016 |
|
|
|
| Book Value |
|
| 100.5174369 |
|
|
|
| Mar.Cap(Rs.Cr) |
|
| 40,225.46 |
|
|
|
| P/E |
|
| 42.50 |
|
|
|
| Face Value |
|
| 10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Years | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | | Debt-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | | Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | | Current Ratio | 1.32 | 1.47 | 1.83 | 1.89 | 1.77 | | Fixed Assets | 5.51 | 5.17 | 5.23 | 5.38 | 2.84 | | Inventory | 7.62 | 7.16 | 6.77 | 6.21 | 5.80 | | Debtors | 14.47 | 16.44 | 16.18 | 15.29 | 18.52 | | Interest Cover Ratio | 954.01 | 502.66 | 462.57 | 383.39 | 178.31 | | PBIDTM (%) | 35.36 | 28.60 | 28.08 | 25.83 | 24.24 | | PBITM (%) | 33.56 | 26.55 | 26.03 | 23.71 | 21.55 | | PBDTM (%) | 35.32 | 28.55 | 28.02 | 25.77 | 24.12 | | CPM (%) | 26.48 | 21.16 | 20.94 | 54.31 | 18.97 | | APATM (%) | 24.68 | 19.11 | 18.90 | 52.19 | 16.28 | | ROCE (%) | 58.72 | 44.44 | 33.60 | 32.11 | 32.10 | | RONW (%) | 49.23 | 36.83 | 27.43 | 80.45 | 28.49 |
|
|
|
|